CELLICO Inc. (20240321150). AUGMENTED REALITY DEVICES FOR PATIENTS WITH RETINITIS PIGMENTOSA AND MACULAR DEGENERATION simplified abstract
Contents
AUGMENTED REALITY DEVICES FOR PATIENTS WITH RETINITIS PIGMENTOSA AND MACULAR DEGENERATION
Organization Name
Inventor(s)
AUGMENTED REALITY DEVICES FOR PATIENTS WITH RETINITIS PIGMENTOSA AND MACULAR DEGENERATION - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240321150 titled 'AUGMENTED REALITY DEVICES FOR PATIENTS WITH RETINITIS PIGMENTOSA AND MACULAR DEGENERATION
The present disclosure introduces an augmented reality (AR) device designed for patients with retinitis pigmentosa and macular degeneration. This device includes a map providing unit, a region setting unit, and a region display unit.
- The map providing unit drives scanning points in wearable glasses to create a scotoma map based on the user's input signal.
- The region setting unit establishes the user's scotoma region using the scotoma map.
- The region display unit shows an external image corresponding to the scotoma region in the display area.
Potential Applications: - Assistive technology for individuals with visual impairments - Medical devices for retinitis pigmentosa and macular degeneration patients
Problems Solved: - Enhances visual perception for those with retinal conditions - Provides a customized solution for each user's specific scotoma
Benefits: - Improves quality of life for visually impaired individuals - Offers personalized support for different eye conditions
Commercial Applications: - Medical device industry - Assistive technology market for individuals with disabilities
Questions about the technology: 1. How does this AR device differ from traditional visual aids for visually impaired individuals? 2. What are the potential limitations of this technology in real-world usage?
Frequently Updated Research: Ongoing studies focus on optimizing the device's accuracy and user experience for better integration into daily life for patients with retinal conditions.
Original Abstract Submitted
the present disclosure provides an augmented reality (ar) device for patients with retinitis pigmentosa and macular degeneration comprising a map providing unit, a region setting unit, and a region display unit, wherein the map providing unit sequentially drives a plurality of scanning points included in a display of wearable glasses to provide a scotoma map wherein a user's scotoma is checked according to the user's input signal, the region setting unit sets the user's scotoma region based on the scotoma map; the region display unit displays an external image corresponding to the scotoma region in a display region included in the display.
